Lawyers Pursue Skin Cancer Cases After Medication Use

(NewsUSA) - The anti-inflammatory medication dupilumab, marketed as Dupixent, is the subject of a lawsuit alleging a link between the use of the medication and the development of a type of skin cancer known as cutaneous T-cell lymphoma (CTCL).

Dupixent is prescribed for several medical conditions including asthma and eczema. CTCL is a type of skin cancer that develops in white blood cells, which help the body fight infection.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.